Harry Cook,Martha Hamilton,Douglas Danielson,Colette Goderstad,Dayton Reardan
申请号：
US13182324
公开号：
US20120020833A1
申请日:
2011.07.13
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient.
